Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02471651
What this trial is testing

Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
California Retina Consultants 40
Not applicableStudy completedNCT05037396
What this trial is testing

Evaluation of Number of Patient Eyes That Remained on or Switched to Anti-VEGF Treatment After Initiation of Broluciumab

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 9,457
Testing effectiveness (Phase 2)Study completedNCT00016094
What this trial is testing

S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+1 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00607750
What this trial is testing

Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF

Who this might be right for
Age-Related Macular Degeneration
CoMentis 60
Large-scale testing (Phase 3)Ended earlyNCT04603937
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Kodiak Sciences Inc 459
Testing effectiveness (Phase 2)Study completedNCT00841581
What this trial is testing

Lucentis to Treat Pigment Epithelial Detachment

Who this might be right for
Pigment Epithelial Detachment
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 32
Post-approval studies (Phase 4)Study completedNCT02577107
What this trial is testing

Head to Head Study of Anti-VEGF Treatment.

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04356729
What this trial is testing

A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Stage IV MelanomaUnresectable Stage III Cutaneous Melanoma+1 more
F. Stephen Hodi, MD 30
Testing effectiveness (Phase 2)Study completedNCT02134457
What this trial is testing

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity (ROP)
University Hospital Freiburg 19
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Early research (Phase 1)Study completedNCT00416637
What this trial is testing

Bevacizumab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Herbert Hurwitz, MD 27
Not applicableUnknownNCT05717738
What this trial is testing

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Tongji Hospital 300
Large-scale testing (Phase 3)Study completedNCT01909791
What this trial is testing

Treatment for CI-DME in Eyes With Very Good VA Study

Who this might be right for
Diabetic Macular Edema
Jaeb Center for Health Research 702
Not applicableUnknownNCT03866005
What this trial is testing

Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema

Who this might be right for
Center-involved Diabetic Macular Edema (CI-DME)
ZeaVision, LLC 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 139
Not applicableStudy completedNCT03833830
What this trial is testing

Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment

Who this might be right for
Neovascular Age-related Macular Degeneration
Dr. med. Katja Hatz 40
Testing effectiveness (Phase 2)Looking for participantsNCT06827236
What this trial is testing

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast CancerUnresectable Breast CarcinomaMetastatic Breast Cancer
BioNTech SE 380
Not applicableUnknownNCT03128463
What this trial is testing

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Who this might be right for
Age-Related Macular DegenerationPolypoidal Choroidal VasculopathyPathological Myopia+2 more
Xun Xu 5,000
Large-scale testing (Phase 3)UnknownNCT00710229
What this trial is testing

Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Not applicableStudy completedNCT01425112
What this trial is testing

Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy

Who this might be right for
Complications of TreatmentProgression
Sudhalkar Eye Hospital 180
Next Page